Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Krystal Biotech Inc (KRYS)

10.48 -0.27 (-2.51%)

05-22 11:19

Open:

10.76

Pre. Close:

10.75

High:

10.9

Low:

10.48

Volume:

5,928

Market Cap:

108M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

11.213 - 11.257

11.257 - 11.296

Low:

10.6 - 10.653

10.653 - 10.7

Close:

10.658 - 10.745

10.745 - 10.82

Technical analysis  (as of: 2018-05-22 11:11:47 AM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 13.08     One year: 15.28

Support:

Support1: 9.78    Support2: 8.91

Resistance:

Resistance1: 11.20    Resistance2: 13.08

Pivot:

10.22

Moving Averages:

MA(5): 10.47     MA(20): 10.05

MA(100): 9.90     MA(250):

MACD:

MACD(12,26): 0.16     Signal(12,26,9): 0.10

%K %D:

%K(14,3): 46.66     %D(3): 50.63

RSI:

RSI(14): 55.08

52-Week:

High: 12  Low: 8.03  Change(%): -0.8

Average Vol(K):

3-Month: 1709  10-Days 2928

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
KRYS has closed below upper band by 26.0%. Bollinger Bands are 22.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-10T02:04:51-04:00
Institutional Top Ideas Series: Ra Capital Management

2018-05-08T13:08:53-04:00
Krystal Biotech: Important Catalyst And Value Inflection Point Approaching

2018-04-26T09:56:09-04:00
FDA on board with clinical development of Krystal Biotech's KB103 for skin blistering disorder; shares up 3%

2018-04-19T10:39:02-04:00
Krystal Biotech's KB103 an Orphan Drug in Europe for DEB

2018-04-18T15:41:37-04:00
Catalyst Pipeline Portfolio Updates - Strong Start To For The Portfolio

2018-04-17T03:23:07-04:00
Reader Inquiry: Why Is Krystal Biotech Not Participating In The Rally In Gene Therapy Stocks?

2018-04-09T07:19:12-04:00
Novartis takeout of AveXis stokes buying in gene therapy players

2018-03-28T08:00:00-04:00
Your Daily Pharma Scoop: Esperion Gains On Data, AnaptysBio's ANB020, Tesaro Reports Promising Data

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

10.31

Shares Float (M)

6.13

% Held by Insiders

40.50

% Held by Institutions

38.70

Shares Short (K)

47

Shares Short Prior Month (K)

31

Stock Financials

EPS

-1.470

EPS Est. Current Year

-1.320

EPS Est. Next Year

-2.180

EPS Est. Next Quarter

Forward EPS

-2.411

Book Value (p.s.)

2.200

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-20.0

Return on Equity (ttm)

-20.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.203

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.00

Levered Free Cash Flow (M)

-5.93

atoplab.com

Valuation

P/E

-7.18

P/E Growth Ratio

-0.02

P/BV

4.80

P/S

P/CF

-18.14

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.